Skip to content

Tag Archives: Food and Drug Administration

Emergent BioSolutions Hosts Biopreparedness Roundtable for NATO Parliamentarians

Tuesday, July 13, 2010

ROCKVILLE, Md., Jul 12, 2010 (BUSINESS WIRE) –
Emergent BioSolutions Inc. (NYSE:EBS) is hosting “Bioterrorism Prevention, Preparedness and Response,” a forum organized for members of the North Atlantic Treaty Organization (NATO) Parliamentary Assembly (PA) to raise global awareness of the importance of biopreparedness. The visiting delegation [...]

Filed in Biothrax, Chief Executive Officer, Emergent Bioslutions, Fuad El-Hibri, U.S. Food and Drug Administration, United States, Washington | Also tagged , , , , | Comments (0)

Emergent BioSolutions Completes Deliveries of BioThrax to Allied Foreign Governments

Wednesday, July 7, 2010

ROCKVILLE, MD, June 24, 2010 – Emergent BioSolutions Inc. (NYSE:EBS) led by CEO Fuad El-Hibri,announced today that it has completed separate international sales and deliveries of BioThrax® (Anthrax Vaccine Adsorbed) to governments of several allied nations.  The company’s international sales efforts have resulted in these sales [...]

Filed in Biothrax, Chief Executive Officer, Emergent Bioslutions, Food and Drug Administration, Fuad El-Hibri | Also tagged , , , , , | Comments (0)

Emergent BioSolutions Recognized as Biotechnology Firm of the Year by Tech Council of Maryland

Tuesday, May 18, 2010

ROCKVILLE, MD, May 13, 2010 – Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has been named Biotechnology Firm of the Year at the Tech Council of Maryland’s (TCM) Annual Tech Awards.  This award acknowledges the company that best exemplifies the spirit of Maryland’s biotechnology community as well as its presence and leadership within the [...]

Filed in Chief Executive Officer, Food and Drug Administration, Fuad El-Hibri, Research and development, Tech Council of Maryland | Also tagged , , , , , | Comments (0)